Classification of genetic profiles of Crohn's disease: A focus on the ATG16L1 gene

Expert Review of Molecular Diagnostics

Volumn 8, Issue 2, 2008, Pages 199-207

  Grant, Struan F A ^b,c   Baldassano, Robert N ^c   Hakonarson, Hakon ^a,b,c  

^a Center for Applied Genomics   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ATG16L1; Autophagy related 16 like 1 gene; Crohn's disease; Genome wide association; Single nucleotide polymorphism

Indexed keywords

ALANINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE RECEPTOR; INTERLEUKIN 23 RECEPTOR; THREONINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ASTHMA; AUTOPHAGY; AUTOPHAGY RELATED 16 LIKE 1 GENE; BREAST CANCER; CROHN DISEASE; ENTERITIS; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; AUTOPHAGY; CARRIER PROTEINS; COLITIS, ULCERATIVE; CROHN DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; QUANTITATIVE TRAIT LOCI; RECEPTORS, INTERLEUKIN; TWIN STUDIES AS TOPIC;

EID: 41549098375     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.8.2.199     Document Type: Review

References (89)

1. Travis SP, Stange EF, Lemann M et al. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 55(Suppl. 1), I16-I35 (2006).
2. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 347(6), 417-429 (2002).
3. Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat. Rev. 6(5), 376-388 (2005).
4. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3(7), 521-533 (2003).
5. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. 3(7), 390-407 (2006).
6. Kirsner JB, Spencer JA. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis. Ann. Intern. Med. 59, 133-144 (1963).
7. Halme L, Paavola-Sakki P, Turunen U et al. Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 12(23), 3668-3672 (2006).
8. Orholm M, Munkholm P, Langholz E et al. Familial occurrence of inflammatory bowel disease. N. Engl. J. Med. 324(2), 84-88 (1991).
9. Peeters M, Nevens H, Baert F et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 111(3), 597-603 (1996).
10. Yang H, McElree C, Roth MP et al. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 34(4), 517-524 (1993).
11. Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut 40(5), 572-574 (1997).
12. Polito JM II, Childs B, Mellits ED et al. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111(3), 580-586 (1996).
13. Grandbastien B, Peeters M, Franchimont D et al. Anticipation in familial Crohn's disease. Gut 42(2), 170-174 (1998).
14. Colombel JF, Grandbastien B, Gower-Rousseau C et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111(3), 604-607 (1996).
15. Annese V, Andreoli A, Andriulli A et al. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am. J. Gastroenterol. 96(8), 2407-2412 (2001).
16. Bayless TM. Maintenance therapy for Crohn's disease. Gastroenterology 110(1), 299-302 (1996).
17. Peeters M, Cortot A, Vermeire S, Colombel JF. Familial and sporadic inflammatory bowel disease: different entities? Inflamm. Bowel Dis. 6(4), 314-320 (2000).
18. Orholm M, Binder V, Sorensen TI, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand. J. Gastroenterol. 35(10), 1075-1081 (2000).
19. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 124(2), 521-536 (2003).
20. Duerr RH. Update on the genetics of inflammatory bowel disease. J. Clin. Gastroenterol. 37(5), 358-367 (2003).
21. Lazaridis KN, Petersen GM. Genomics, genetic epidemiology, and genomic medicine. Clin. Gastroenterol. Hepatol. 3(4), 320-328 (2005).
22. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312(7023), 95-96 (1996).
23. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29(7), 990-996 (1988).
24. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 367(9518), 1271-1284 (2006).
25. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124(7), 1767-1773 (2003).
26. Breslin NP, Todd A, Kilgallen C, O'Morain C. Monozygotic twins with Crohn's disease and ulcerative colitis: a unique case report. Gut 41(4), 557-560 (1997).
27. Tysk C. Genetic susceptibility in Crohn's disease - review of clinical studies. Eur. J. Surg. 164(12), 893-896 (1998).
28. Mathew CG, Lewis CM. Genetics of inflammatory bowel disease: progress and prospects. Hum. Mol. Genet. 13(Spec. No 1), R161-R168 (2004).
29. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411(6837), 599-603 (2001).
30. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411(6837), 603-606 (2001).
31. Hampe J, Cuthbert A, Croucher PJ et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357(9272), 1925-1928 (2001).
32. Rioux JD, Daly MJ, Silverberg MS et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29(2), 223-228 (2001).
33. Mirza MM, Fisher SA, King K et al. Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am. J. Hum. Genet. 72(4), 1018-1022 (2003).
34. Peltekova VD, Wintle RF, Rubin LA et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36(5), 471-475 (2004).
35. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314(5804), 1461-1463 (2006).
36. A haplotype map of the human genome. Nature 437(7063), 1299-1320 (2005).
37. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429(6990), 446-452 (2004).
38. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat. Rev. 6(2), 95-108 (2005).
39. Frazer KA, Ballinger DG, Cox DR et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164), 851-861 (2007).
40. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 444(7118), 444-454 (2006).
41. Reich D, Patterson N, De Jager PL et al. A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat. Genet. 37(10), 1113-1118 (2005).
42. Steemers FJ, Chang W, Lee G et al. Whole-genome genotyping with the single-base extension assay. Nat. Methods 3(1), 31-33 (2006).
43. Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS. A genome-wide scalable SNP genotyping assay using microarray technology. Nat. Genet. 37(5), 549-554 (2005).
44. Hakonarson H, Grant SF, Bradfield JP et al. A genome-wide association study identifies KIAA0350 as a Type 1 diabetes gene. Nature 448, 591-594 (2007).
45. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of Type 1 diabetes. Nat. Genet. 39(7), 857-864 (2007).
46. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145), 661-678 (2007).
47. Sladek R, Rocheleau G, Rung J et al. A genome-wide association study identifies novel risk loci for Type 2 diabetes. Nature 445(7130), 881-885 (2007).
48. Saxena R, Voight BF, Lyssenko V et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316(5829), 1331-1336 (2007).
49. Zeggini E, Weedon MN, Lindgren CM et al. Replication of genome-wide association signals in UK samples reveals risk loci for Type 2 diabetes. Science 316(5829), 1336-1341 (2007).
50. Scott LJ, Mohlke KL, Bonnycastle LL et al. A genome-wide association study of Type 2 diabetes in Finns detects multiple susceptibility variants. Science 316(5829), 1341-1345 (2007).
51. Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science 308(5720), 385-389 (2005).
52. Helgadottir A, Thorleifsson G, Manolescu A et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316(5830), 1491-1493 (2007).
53. McPherson R, Pertsemlidis A, Kavaslar N et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316(5830), 1488-1491 (2007).
54. Easton DF, Pooley KA, Dunning AM et al. Genome-wide association study identifies novel breast cancer susceptibility loci. 447(7148), 1087-1093 Nature (2007).
55. Baldassano RN, Bradfield JP, Monos DS et al. Association of variants of the interleukin-23 receptor (IL23R) gene with susceptibility to pediatric Crohn's disease. Clin. Gastroenterol. Hepatol. Clin. 5(8), 972-976 (2007).
56. Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39(2), 207-211 (2007).
57. Croucher PJ, Mascheretti S, Hampe J et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur. J. Hum. Genet. 11(1), 6-16 (2003).
58. Patterson M, Cardon L. Replication publication. PLoS Biology 3(9), E327 (2005).
59. Page GP, George V, Go RC, Page PZ, Allison DB. "Are we there yet?": deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits. Am. J. Hum. Genet. 73(4), 711-719 (2003).
60. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 4(2), 45-61 (2002).
61. Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39(5), 596-604 (2007).
62. Libioulle C, Louis E, Hansoul S et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3(4), E58 (2007).
63. Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313(5792), 1438-1441 (2006).
64. Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39(7), 830-832 (2007).
65. Roberts RL, Gearry RB, Hollis-Moffatt JE et al. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am. J. Gastroenterol. 102(12), 2754-2761 (2007).
66. Hilmi I, Tan YM, Goh KL. Crohn's disease in adults: observations in a multiracial Asian population. World J. Gastroenterol. 12(9), 1435-1438 (2006).
67. Law NM, Lim CC, Chong R, Ng HS. Crohn's disease in the Singapore Chinese population. J. Clin. Gastroenterol. 26(1), 27-29 (1998).
68. Yang SK, Hong WS, Min YI et al. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J. Gastroenterol. Hepatol. 15(9), 1037-1042 (2000).
69. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm. Bowel Dis. 10(5), 646-651 (2004).
70. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126(6), 1504-1517 (2004).
71. Yamazaki K, Onouchi Y, Takazoe M et al. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J. Hum. Genet. 52(7), 575-583 (2007).
72. Baldassano RN, Bradfield JP, Monos DS et al. Association of the T300A nonsynonymous variant of the ATG16L1 gene with susceptibility to paediatric Crohn's disease. Gut 56(8), 1171-1173 (2007).
73. Prescott NJ, Fisher SA, Franke A et al. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 132(5), 1665-1671 (2007).
74. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am. J. Hum. Genet. 66(6), 1857-1862 (2000).
75. Hampe J, Schreiber S, Shaw SH et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am. J. Hum. Genet. 64(3), 808-816 (1999).
76. Shaw SH, Hampe J, White R et al. Stratification by CARD15 variant genotype in a genome-wide search for inflammatory bowel disease susceptibility loci. Hum. Genet. 113(6), 514-521 (2003).
77. Zheng H, Ji C, Li J et al. Cloning and analysis of human Apg16L. DNA Seq. 15(4), 303-305 (2004).
78. Mizushima N, Kuma A, Kobayashi Y et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell Sci. 116(Pt 9), 1679-1688 (2003).
79. Kuma A, Mizushima N, Ishihara N, Ohsumi Y. Formation of the approximately 350-kDa Apg12-Apg5.Apg16 multimeric complex, mediated by Apg16 oligomerization, is essential for autophagy in yeast. J. Biol. Chem. 277(21), 18619-18625 (2002).
80. Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281(16), 11374-11383 (2006).
81. Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of Type 2 diabetes. Nat. Genet. 38(3), 320-323 (2006).
82. Zeggini E, McCarthy MI. TCF7L2: the biggest story in diabetes genetics since HLA? Diabetologia, 50(1), 1-4 (2007).
83. Schmid D, Dengjel J, Schoor O, Stevanovic S, Munz C. Autophagy in innate and adaptive immunity against intracellular pathogens. J. Mol. Med. 84(3), 194-202 (2006).
84. Deretic V. Autophagy as an immune defense mechanism. Curr. Opin. Immunol. 18(4), 375-382 (2006).
85. Dengjel J, Schoor O, Fischer R et al. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl Acad. Sci. USA 102(22), 7922-7927 (2005).
86. Smyth DJ, Cooper JD, Bailey R et al. A genome-wide association study of nonsynonymous SNPs identifies a Type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38(6), 617-619 (2006).
87. Deretic V. Autophagy in innate and adaptive immunity. Trends Immunol. 26(10), 523-528 (2005).
88. Amer AO, Byrne BG, Swanson MS. Macrophages rapidly transfer pathogens from lipid raft vacuoles to autophagosomes. Autophagy 1(1), 53-58 (2005).
89. Nakagawa I, Amano A, Mizushima N et al. Autophagy defends cells against invading group A Streptococcus. Science 306(5698), 1037-1040 (2004).